nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferasirox—Cytochrome P450 1A2 Inhibitors—Vemurafenib—skin cancer	0.842	1	CiPCiCtD
Deferasirox—CYP3A4—Temozolomide—skin cancer	0.046	0.292	CbGbCtD
Deferasirox—CYP3A4—Imiquimod—skin cancer	0.046	0.292	CbGbCtD
Deferasirox—CYP3A4—Vismodegib—skin cancer	0.0319	0.202	CbGbCtD
Deferasirox—CYP3A4—Vemurafenib—skin cancer	0.0252	0.16	CbGbCtD
Deferasirox—CYP3A4—Docetaxel—skin cancer	0.00866	0.0548	CbGbCtD
Deferasirox—Magnesium salicylate—PTGS2—skin cancer	0.000334	0.54	CrCbGaD
Deferasirox—Salsalate—PTGS2—skin cancer	0.000284	0.46	CrCbGaD
